Investec Structured Products Calculus VCT plc
Issue of Equity
The Directors of Investec Structured Products Calculus VCT plc are pleased to
announce an allotment on 5 October 2010 of 115,830 ordinary shares of 1p each
("Ordinary Shares") at an offer price of 103.6p per share, pursuant to the
offer for subscription that opened on 20 September 2010 (the "Offer").
As set out in the prospectus, the offer price is based on an adjusted unaudited
net asset value per Ordinary Share of 98.42p as at 1 October 2010, divided by
0.95 (to allow for offer costs of 5.0 per cent.), rounded up to the nearest
0.1p per share.
Application for the Ordinary Shares to be admitted to the Official List of the
UK Listing Authority and to trading on the London Stock Exchange's main market
for listed securities has been made and it is expected that admission will take
place on 6 October 2010.
Following these allotments the issued share capital of the Company is 3,983,747
Ordinary Shares.
For further enquiries please contact:
Gary Dale (Investec Structured Products)
Tel: 020 7597 4065
Email: gary.dale@investec.co.uk
Susan McDonald (Calculus Capital)
Tel: 0207 493 4940
Email: info@calculuscapital.com
5 October 2010
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.